Vimian Pharma Holding AB
ActiveKey figures
Key figures
2025Summary: Vimian Pharma Holding AB
What kind of company is it?
Vimian Pharma Holding AB (org. no. 559133-6093) is a limited company (AB). The company was registered in 2017 and has existed for 9 years. Registered seat: Stockholm.
How is the company doing financially?
The company had no net sales in financial year 2025. Net profit for 2025 was 3 000 kr. The company was profitable in all 3 reported financial years. At the end of financial year 2025, total assets were 1 756 276 000 kr and equity 1 729 469 000 kr (equity ratio 98,5 %).
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 4 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Dividend
from the annual reportProposed dividend 26 666 204 kr.
Summary of annual reports2023–2025
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Sales revenue | 0 | 0 | 0 |
| Profit for the reporting year | 214 000 | 1 150 000 | 3 000 |
| Retained earnings of previous periods | — | — | — |
| Total assets | 1 755 035 000 | 1 756 143 000 | 1 756 276 000 |
| Total liabilities | 53 000 | 11 000 | 26 807 000 |
| Total equity | 1 754 982 000 | 1 756 132 000 | 1 729 469 000 |
| Employees | — | — | — |
| Proposed dividend | — | 26 666 204 | — |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.